Securing Alignment with Regulators Around the Use of Optimal Endpoints & Evidence to Demonstrate Efficacy of Disease Modifying Therapies in Neurodegeneration
Time: 11:30 am
day: Conference Day Two - Track Three
Details:
- Reviewing the evolving regulatory landscape for AD and PD treatments
- What can we learn from approval success stories in AD?
- Navigating regulatory interactions to align on approvable endpoints that can demonstrate treatment efficacy over stand of care
